Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 550 of 5804
-
New drug cocktail targets melanoma brain metastases in early trial
Disease control Recruiting nowThe goal of this interventional clinical trial is to provide proof-of-principle data for the biologic activity of defactinib in combination with avutometinib in brain metastases from melanoma, and to define the potential role of the combination with mutant BRAF inhibitors or afte…
Phase: PHASE1, PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could a single shot before surgery shield your heart?
Prevention Recruiting nowThis is an investigator initiated, multi-center, open-labelled, superiority randomized controlled trial of 372 patients undergoing elective non-cardiac surgery. Recruited patients will be randomized in a 2:1 ratio to receive single subcutaneous dose of Glucagon-like Peptide-1 Rec…
Phase: PHASE4 • Sponsor: The University of Hong Kong • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
New drug TAK-279 targets rare, severe psoriasis in phase 3 trial
Disease control OngoingThe main aim of this study is to check if TAK-279 improves symptoms of With Generalized Pustular Psoriasis (GPP) or Erythrodermic Psoriasis (EP) and side effect from the study treatment or TAK-279. All participants will be assigned to study treatments of TAK-279 and will be trea…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New combo shot CagriSema shows promise for diabetes and weight loss
Disease control CompletedThis study will look at how much CagriSema helps participants with type 2 diabetes lower their blood sugar and body weight. CagriSema is a new investigational medicine. Doctors may not yet prescribe CagriSema. CagriSema will be compared to a "dummy" medicine (also called "placebo…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New triple therapy takes on pancreatic cancer
Disease control Recruiting nowTo evaluate the efficacy and safety of TQB2868 injection combined with anlotinib capsule and chemotherapy in treated patients with Pancreatic Neoplasms
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 18:59 UTC
-
Gene-Editing hope for thalassemia patients: early trial launched
Disease control ENROLLING_BY_INVITATIONThe goal of this open label, single-arm clinical study is to learn about the safety and efficacy of CS-101 in treating β-thalassemia.
Phase: EARLY_PHASE1 • Sponsor: CorrectSequence Therapeutics Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Engineered immune cells aim to clear leukemia before transplant
Disease control Recruiting nowThis study is designed as a single arm open label traditional Phase I, 3+3, study of CD4-redirected chimeric antigen receptor engineered T-cells (CD4CAR) in subjects with relapsed or refractory AML. The study will evaluate safety in this subject population and also the presence o…
Phase: PHASE1 • Sponsor: Huda Salman • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Smart bracelets could shave minutes off stroke treatment time
Disease control CompletedThis study intends to construct the goal-oriented integrated intervention model through the intelligent bracelet automatic positioning and feedback system based spatiotemporal computing technology (FAST model) to promote the reconstruction of workflow in stroke centers and to sho…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
India study aims to match depression patients to best therapy or drug
Disease control OngoingThe OptimizeD study aims to improve outcomes in depression in primary care in India. This study will randomize 1500 patients with moderate to severe depression to either psychotherapy based on behavioral activation called the Healthy Activity Program (HAP) or antidepressant medic…
Phase: PHASE3 • Sponsor: Harvard Medical School (HMS and HSDM) • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New surgery aims to stop arm swelling after breast cancer treatment
Prevention Recruiting nowThis study aims to evaluate the effectiveness of the Lymphovenous Bypass (LVB) procedure compared to physiotherapy alone as secondary prevention of lymphedema in breast cancer patients undergoing axillary lymph node dissection.
Phase: NA • Sponsor: Dharmais National Cancer Center Hospital • Aim: Prevention
Last updated Jun 27, 2026 07:57 UTC
-
New weekly shot shows promise for obesity weight loss
Disease control CompletedThis study will look at how a new medicine called NNC0519-0130 helps people with excess body weight lose weight. The study will test up to 6 different doses of NNC0519-0130. Participants will take 1-2 injections once a week. The study medicine will be injected under skin with a t…
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can a nutrient in eggs keep malnourished kids from getting worse?
Disease control OngoingThe goal of this clinical trial is to test choline supplementation in children with moderate acute malnutrition in Malawi. The main question it aims to answer is: Will provision of RUSF with added choline (500mg/day) throughout treatment of moderate acute malnutrition (up to 12 …
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New antibody could reduce bleeding after stroke
Disease control Recruiting nowSISTER is a Phase-II, prospective, randomized, placebo-controlled, blinded, dose finding trial that aims to determine the safety and preliminary efficacy of TS23, a monoclonal antibody against the alpha-2 antiplasmin (a2-AP), in acute ischemic stroke.
Phase: PHASE2 • Sponsor: Translational Sciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a wakefulness drug lift depression? new trial tests solriamfetol
Symptom relief CompletedPARADIGM (Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol) is a Phase 3, randomized, double-blind, placebo-controlled, multicenter trial to assess the safety and efficacy of solriamfetol for the treatment of major depressive disorder (MDD) in adu…
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New gel could slash facial skin cancers in rare genetic condition
Disease control OngoingThe aim of this clinical study is to find out how well Patidegib Gel 2% works in preventing new basal cell carcinomas (BCCs) developing on the face of adults with Gorlin syndrome, and how safe Patidegib Gel 2% is to use. People who take part will apply either Patidegib Gel 2% or…
Phase: PHASE3 • Sponsor: Sol-Gel Technologies, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Immunotherapy boosts standard treatment for rectal cancer in new trial
Disease control Recruiting nowThe goal of this clinical trial is to compare the efficacy and safety of neoadjuvant chemoradiotherapy combined with tirelizumab compared with neoadjuvant chemoradiotherapy alone for neoadjuvant therapy in patients with locally advanced rectal cancer. The main questions it aims …
Phase: PHASE2, PHASE3 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Could a Pre-IVF pill boost baby chances for endometriosis patients?
Disease control OngoingA Phase 3 clinical trial of oral GnRH antagonist pre-treatment for women with endometriosis who are undergoing IVF, with a primary outcome of live birth rate. The investigators' central hypothesis is that in infertile woman with endometriosis undergoing in vitro fertilization-emb…
Phase: PHASE3 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Could earlier aspirin save lives in sickle cell pregnancies?
Disease control OngoingThis study is being conducted to evaluate the safety and effect of starting daily use of low dose (100 mg) aspirin in pregnant women with sickle cell disease, who are being followed in two county hospitals in Angola, in the first trimester versus the second trimester of the gesta…
Phase: PHASE1, PHASE2 • Sponsor: Instituto Nacional de Investigacao em Saude, Angola • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Eye drops could replace needles for Diabetes-Related vision loss
Disease control CompletedThe primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of OCS 01 as compared to Vehicle in participants with Diabetic Macular Edema (DME).
Phase: PHASE3 • Sponsor: Oculis • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could a second round of radiation boost survival in returning brain tumors?
Disease control Recruiting nowDespite comprehensive multimodal treatment of newly diagnosed glioblastoma, almost all patients suffer from tumour relapse. Currently, no standard of care exists to treat these tumour relapses. Treatment options include repeated surgery (if feasible), systemic therapy (bevacizuma…
Phase: PHASE3 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC